High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy-Reference-Cited by-同舟云学术

High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy

Published:2015-04-06 Issue:7 Volume:137 Page:1643-1651
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Haruyama Yukihiro¹²,Yorita Kenji¹,Yamaguchi Tetsuji³,Kitajima Sachiko⁴,Amano Jun⁵,Ohtomo Toshihiko⁵,Ohno Akinobu⁶,Kondo Kazuhiro²,Kataoka Hiroaki¹

Affiliation:

1. Section of Oncopathology and Regenerative Biology; Department of Pathology; Faculty of Medicine; University of Miyazaki; Miyazaki Japan

2. Department of Surgical Oncology and Regulation of Organ Function; Faculty of Medicine; University of Miyazaki; Miyazaki Japan

3. San Diego Laboratory; JSR Life Sciences Corporation; La Jolla CA

4. Business Planning Department; JSR Life Sciences Corporation; Ibaraki Japan

5. Safety Assessment Department; Chugai Pharmaceutical Co.; Ltd; Tokyo Japan

6. Pathology Section; University of Miyazaki Hospital; Miyazaki Japan

Funder

Collaborative Research Fund from Chugai Pharmaceutical Co., Tokyo, Japan; Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29518/fullpdf

Reference32 articles.

1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

2. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma;Filmus;FEBS J,2013

3. Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients;Ning;Mol Biol Rep,2012

4. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma;Shirakawa;Cancer Sci,2009

5. Prognostic significance of circumferential cell surface immunoreactivity of glypican 3 in hepatocellular carcinoma;Yorita;Liver Int,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

2. Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?;International Journal of Molecular Sciences;2024-02-23

3. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions;Biomolecules;2023-09-09

4. GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma;Reports of Practical Oncology and Radiotherapy;2023-08-28

5. Glypicans, 35 years later;Proteoglycan Research;2023-04